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Abstract The Ca2+-dependent protein phosphatase activity of 
crude rat brain extracts measured in the presence of okadaic acid, 
exhibits the characteristic properties of the calmodulin-stimn- 
lated protein phosphatase, calcineurin. It is stimulated more than 
200-fold by Ca 2+ and inhibited by the calmodnlin-binding peptide, 
MI3, and by the immunosuppressive drug, FKS06. It is insensitive 
to rapamycin at concentrations up to 1 pM. Its specific activity, 
based on calcineurin concentration determined by quantitative 
analysis of Western blots exposed to anti-bovine brain IgG, is ten 
to twenty times that of purified rat brain calcineurin assayed 
under similar conditions. Unlike the purified enzyme it is rapidly 
and irreversibly inactivated in a time-, temperature-, and Ca2+/ 
calmodulin-dependent fashion without evidence of extensive pro- 
teolytic degradation. The enzyme is converted to a state which 
does not lose activity by removal of low molecular weight material 
by gel filtration. Reconstitution of a labile enzyme is achieved by 
the addition of the low molecular weight-containing fraction 
elnted from the gel filtration column. These observations indicate 
that calcineurin in crude brain extracts is under the control of 
Ca2+/calmodulin-dependent positive and negative regulatory 
mechanisms which involve unidentified endogenous factor(s). 
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1. Introduction 
The specific inhibition of the calmodulin-stimulated protein 
phosphatase, calcineurin j, by the immunosuppressive drugs, 
FK506 and cyclosporin A, complexed with their respective 
binding proteins, cyclophilin and FKBP, suggests that these 
agents may be competing with endogenous ligands modulating 
the activity of calcineurin in vivo [10,12]. In an attempt to 
demonstrate the presence of such regulatory factors we ana- 
lyzed the activity of calcineurin in crude brain extracts. Brain 
extracts were selected because the concentration of calcineurin 
ICalcineurin is the sole identified member of the protein phosphatase- 
2B family defined by Ingebritsen and Cohen [5]. 
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in this tissue, determined by Western blot analysis, is ten to 
twenty times that of skeletal muscle [8] whereas the protein 
phosphatase activities of calcineurin in brain and skeletal mus- 
cle are apparently similar [6]. Endogenous inhibitory ligands 
could be responsible for the relatively low specific activity of 
calcineurin in crude brain extracts. The high concentration of 
the FK506-binding protein, FKBP, in brain [14] also suggests 
that it may be accompanied by equally high concentration of 
these putative regulatory ligands. 
2. Materials and methods 
2.1. Mater&ls 
Ram testis calmodulin was purified as described by Newton et al. 
[13]. FK506 and rapamycin were generous gifts from S. Schreiber (Har- 
vard University) and okadaic acid from A. Takai (Nagoya University). 
The synthetic peptide used as a substrate for calcineurin [1] purchased 
from Peninsula Laboratories, was purified by HPLC and 
phosphorylated with cAMP-dependent kinase as described by Hubbard 
and Klee [4]. The synthetic peptide corresponding to the calmodulin- 
binding domain of myosin light chain kinase (M13), used as a specific 
calmodulin inhibitor [1], was purchased from Peptide Technologies 
(Rockville, MD). The antibody against the two subunits of bovine brain 
calcineurin was raised in rabbits and the IgG fraction purified by 
ammonium sulfate fractionation. ~25I-labeled protein A (30 mCi/mg) 
was a product of Amersham. 
2.2. Crude brain extract 
A normally fed Sprague-Dawley rat was injected with a lethal dose 
of pentobarbital nd decapitated. The brain was excised (approxi- 
mately 1.5 g of tissue) and immediately homogenized in 2 volumes of 
250 mM sucrose containing 2 mM EDTA, 0.1% mercaptoethanol, and 
a cocktail of protease inhibitors (100 ¢tg/ml phenylmethyl sulfonyl flu- 
oride, 10¢tg/ml leupeptin and 100/lg/ml soybean trypsin inhibitor) with 
a 15 ml Dounce ball homogenizer at0°C (6-7 strokes) followed by a 
15-s homogenization in a Polytron Model PT 10/35 homogenizer (set- 
ting #5). The homogenate was centrifuged at10,000 × g for 10 min. The 
supernatant fluid (crude extract) was separated from low-Mr material 
by passage through a 1.5 x 10 cm Sephadex G-50 column equilibrated 
with 50 mM Tris-C1, pH 7.5, 0.1 mM EDTA, 0.1% mercaptoethanol 
and a cocktail of protease inhibitors as above. Fractions containing 
most of the A280.m-absorbing material eluted at the void volume of the 
column were pooled (fraction A, 4 ml) and used to measure the protein 
phosphatase activity of calcineurin. A second peak of UV-absorbing 
material was eluted after one column volume (fraction B, 7 ml). Frac- 
tion B was tested for its ability to alter the calcineurin activity of 
fraction A. The crude extract and the two G-50 fractions were stored 
in 50-/11 aliquots at -70°C for up to six months without significant loss 
of activity. 
2.3. Quantification of cale&eurin & crude extracts 
The crude brain extract was mixed with a denaturing solution con- 
taining 6 M urea, 1% sodium dodecylsulfate (SDS), 0.8 M dithiothreitol 
and 50 mM Tris-C1, pH 8.0. The samples (7.5 pg protein) were boiled 
for 1 min and subjected to SDS-PAGE on 5 10% gradients of 
acrylamide. The resolved protein bands were transferred electro- 
phoretically (20 h at 0°C and 200 mA) to 0.l-tim nitrocellulose filters 
as described [16]. The nitrocellulose filters were blocked with 1% oval- 
bumin and incubated for 90 min in a solution of anticalcineurin IgG 
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(20 mg/ml) diluted 1000-fold in phosphate buffered saline (PBS) con- 
taining 1% ovalbumin and rinsed once with PBS, twice with PBS con- 
taining 0.05% NP40 and once again with PBS• Calcineurin-bound lgG 
was detected with [J25I]protein A (0.1/2Ci/ml in PBS/I% ovalbumin). 
The radioactive bands identified by autoradiography were cut out and 
counted in a gamma counter• Linear responses were obtained between 
5 and 75 ng calcineurin per lane. Bovine brain calcineurin was used as 
a standard• Protein concentration was determined by the method of 
Lowry et al. [11] with bovine serum albumin as standard. 
2.4. Protein phosphatase assay 
The assays were carried out essentially as described by Hubbard and 
Klee [4]. Briefly the crude extract or fraction A (10/2g protein) in 40 
/21 of 40 mM Tris-Cl, pH 8.0, 100 mM KC1, 0.4 mg/ml bovine serum 
albumin (Buffer I) containing 1.5 mM dithiothreitol, and 0.45 /2M 
calmodulin, 0.75/2M okadaic acid (except when indicated otherwise), 
was incubated at 30°C in the presence of Ca 2÷ or EGTA at the concen- 
trations and for the times indicated in legends to the figures. Appropri- 
ate dilution of a stock solution of okadaic acid (4 mM in dimethylsul- 
foxide) in Buffer I was used to achieve a final concentration fdinaeth- 
ylsulfoxide in the phosphatase assay of 0.2% (v/v). Reactions were 
started by addition of 20/21 phosphopeptide issolved in Buffer 1 to 
reach a final concentration of 1/2M and the incubation continued for 
up to 2 min. Except when indicated otherwise, the Ca2÷-dependent 
activity was measured in the presence of 0.66 mM Ca 2÷ and 0.33 mM 
EGTA. The enzyme activity was calculated as described [7]. 
3. Results and discussion 
The immunosuppressant FK506, a specific inhibitor of the 
protein phosphatase activity of calcineurin, inhibits selectively 
the Ca2+-dependent protein phosphatase activity of a crude 
brain extract (Fig. 1, panel A). Because of a rapid loss of 
enzyme activity following exposure of the extract to Ca 2÷ the 
incubation with FK506 was limited to 2 min, followed by a 
1-min incubation with substrate. Under these conditions maxi- 
mal effects of FK506 were observed. Almost complete inhibi- 
tion (> 90%) is observed at 1/2M FK506. As expected from the 
high concentration FK506-binding protein (FKBP) reported in 
brain by Steiner et al. [14] the inhibition does not require addi- 
tion of exogenous FKBP. The high concentration of FK506 
(1/,tM) needed for full inactivation compared to that required 
to inhibit calcineurin activity of Jurkat cell lysates (< 1 nM) [3] 
may reflect the presence of competing ligands, a 10-20-fold 
higher concentration of calcineurin in brain than in other tis- 
sues or both. Attempts to prevent the inhibitory effect of 
Table 1 
Lack of correlation between proteolysis and loss of enzyme activity ~
Additions % Residual Activity % Residual calcineurin 
A subunit B subunit 
None 7-8 53 102 
Mg 2÷ 14-16 78 103 
Mg 2+ + leupeptin 14-17 74 103 
~Crude brain extract was incubated for 20 min at 30°C in the presence 
of 0.15 mM CaCI2 in the presence or absence of 6 mM MgC12 and 10 
mg/ml eupeptin as indicated. Duplicate samples were frozen in dry ice 
and analyzed by SDS gel electrophoresis while the remaining enzyme 
was tested for enzyme activity by addition of substrate and incubation 
continued for 1 min. Calcineurin A levels and activity, determined as 
described in methods, were compared to that of a sample kept at 0°C 
in the presence of EGTA. Calcineurin constitutes 0.7 1% of the total 
protein in crude brain extract. Calcineurin B was detected with an 
antibody raised against recombinant calcineurin B to avoid overestima- 
tion of calcineurin B levels due to contamination by calcineurin A 
proteolytic fragments. 
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Fig. 1. Inhibition of protein phosphatase activity in crude brain extracts 
by FK506, okadaic acid, and rapamycin. Crude brain extract was 
incubated with FK506, okadaic acid and rapamycin as described in 
Section 2 for 2 min at 30°C in the presence of 0.1 mM Ca 2+ (*) or 0.2 
mM EGTA (o). Appropriate dilutions of stock solutions of okadaic 
acid (4 mM in dimethylsulfoxide), FK506 or rapamycin (5 mM in 
methanol) in Buffer I were used to achieve the concentrations of drug 
indicated in the abcissa nd to maintain constant final concentrations 
of methanol (0.2%, v/v) or dimethylsulfoxide (0.2%, v/v) that did not 
significantly inhibit enzyme activity. The protein phosphatase assay 
was started by addition of substrate and the incubation continued for 
2 min. Protein phosphatase activity is expressed as nmol/min.mg of 
total protein. 
FK506 by rapamycin, as reported for other tissues, were incon- 
clusive probably because of high concentrations of rapamycin 
needed to titrate high concentrations of FKBP and to compete 
with equally high concentration of FKBP-FK506 complexed 
with its target protein, calcineurin. FK506 has no effect on the 
Ca2+-independent protein phosphatase activity measured in the 
presence of EGTA. 
Okadaic acid, a specific inhibitor of protein phosphatases-1 
and 2A, has no effect on the Ca2+-dependent dephosphoryla- 
tion of the peptide substrate at concentrations up to 1/2M but 
completely inhibits Ca2+-independent dephosphorylation at 
concentration below 0.03/2M (Fig. 1, panel B). The contribu- 
tion of protein phosphatase-2C to the Ca2+-independent and 
okadaic acid-resistant activity (0.05-0.07 nmol/min, mg of total 
protein), measured in the presence of 6 mM Mg 2+, was very low 
(data not shown). As expected, rapamycin at concentrations up 
to 5/2M fails to inhibit either the Ca2+-independent or Ca 2*- 
dependent phosphatase activities (Fig. 1, panel C). 
Thus, the Ca2+-dependent protein phosphatase activity in 
crude brain extract (70% of the total protein phosphatase activ- 
ity measured in the absence of Mg 2+ with this substrate) exhibits 
the characteristic properties of calcineurin. It is therefore puz- 
zling that the specific activity of the enzyme (100-250 nmol/ 
min 'mg calcineurin) based on calcineurin levels determined by 
quantitative Western blots is 10 to 20 times that of the purified 
calcineurin measured under similar conditions but in the pres- 
ence of added Mg 2+. Following the affinity chromatography 
step the purified enzyme becomes dependent on Mn 2. [15] or 
Mg 2+ (C.B. Klee and M.H. Krinks, unpubl, obs.). 
As shown in Fig. 2A, the Ca2+-dependent protein phosphat- 
ase activity of crude brain extract is inactivated in a time- and 
CaZ+-dependent fashion. Extracts incubated at 30°C in the 
presence of EGTA for up to 20 min do not lose activity but a 
similar treatment in the presence of 1 mM Ca 2+ results in more 
than 90% loss of activity 2. The inactivation of calcineurin also 
2Similar inactivation patterns were observed in the presence of 1/2M 
free Ca 2+. 
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requires the presence of calmodulin. Crude calcineurin dissoci- 
ated from endogenous calmodulin by EGTA and preincubated 
in the presence of Ca 2÷ with a peptide corresponding to the 
calmodulin-binding domain of myosin light chain kinase, M 13, 
is not inactivated (Fig. 2B). The loss of activity is not the result 
of extensive proteolysis of calcineurin. As summarized in Table 
1 only 28-47% loss of calcineurin A and no loss of calcineurin 
B were detected by Western blot analysis ofcalcineurin samples 
which had lost 87 93% of their enzymatic activity. The inactiva- 
tion can also not be explained by dephosphorylation f cal- 
cineurin by protein phosphatase-1, 2A or 2C since the incuba- 
tion was performed in the presence of okadaic acid and in the 
absence of Mg 2+. 
To test the possibility that endogenous analogs of FK506 in 
crude brain extracts are responsible for this inactivation proc- 
ess the crude extract was subjected to a gel filtration on a 
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Fig. 2. Ca 2+- and calmodulin-dependent inactivation of calcineurin i  
crude brain extracts. (A) Crude brain extract was incubated as de- 
scribed in Section 2 in the presence of 1/tM added calmodulin, 1 mM 
Ca 2÷ (0) or 0.5 mM EGTA (©) for the times indicated. (B) The crude 
extract was first incubated in the presence of 0.5 mM EGTA and 
without added calmodulin for 10 min in the absence (o) or presence (©) 
of 1 /IM M13. Ca 2÷ (1 mM total concentration) was added and the 
incubation continued for the times indicated. The enzymatic reactions 
were started by addition of substrate dissolved in Buffer I containing 
enough EGTA or Ca z+ to insure identical final concentrations of Ca 2÷ 
(0.66 mM) and EGTA (0.33 mM) in the assays. In panel B, calmodulin 
(1.3/IM, final concentration) was added with the substrate to measure 
enzyme activity. The specific activity of calcineurin the crude extract 
assayed without prior incubation was 150 (©) and 120 (o) nmol/min • mg 
calcineurin (panel A) and 170 (o) and 120 (©) nmol/min .mg calcineurin 
(panel B). 
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Fig. 3. Phosphatase activity of calcineurin separated from endogenous 
inactivating factor(s) by gel filtration of Sephadex G-50. Fraction A 
eluted from the Sephadex G-50 column (4/11) was incubated in the 
presence of Ca > with (o) or without (©) fraction B (8/ll) for the times 
indicated and the reaction was started by the addition of substrate as 
described in legend to Fig. 2A. Also shown is the activity of Fraction 
A incubated in the presence of EGTA without (zx) and with fraction B 
(A). All enzymatic assays were performed in the presence of 0.66 mM 
Ca 2÷ and 0.33 mM EGTA. The specific activity of the enzyme in frac- 
tion A assayed without prior incubation (120 nmol/min.mg in the 
absence of fraction B and 94 in its presence) was taken as 100% activity. 
Sephadex G-50 column to separate the protein phosphatase 
from the putative ndogenous ligand(s). Following gel filtration 
the specific activity of calcineurin assayed in the presence of 
added calmodulin remains high (100-250 nmol/min.mg of cal- 
cineurin) and is still Mg2+-independent. More than 90% inhibi- 
tion of the CaE+-dependent phosphatase activity was observed 
in the presence of 6/.tM M13 or FK506 (0.7 HM). After gel 
filtration complete inhibition by FK506 requires the addition 
of 0.7 ~tM FKBP, indicating that most of the endogenous 
FKBP eluting between the two major UV-absorbing peaks was 
also removed by gel filtration (data not shown). 
As shown in Fig. 3 the enzyme, freed of low-Mr material by 
gel filtration, is no longer inactivated uring the incubation 
with Ca 2+. Thus, the stability of calcineurin activity after gel 
filtration indicates that autodephosphorylation is not responsi- 
ble for the inactivation process of the crude enzyme prior to gel 
filtration. It is therefore likely that small factor(s), responsible 
for the inactivation, have been removed by gel filtration. Re- 
constitution of a labile enzyme is achieved by mixing fractions 
A and B from the G-50 column (Fig. 3). As was observed in 
the case of the crude extract he inactivation induced by frac- 
tion B is dependent on Ca 2÷ but does not require addition of 
exogenous FKBP. The low-Mr inactivating factor(s) in fraction 
B, that are responsible for the time- and temperature-dependent 
inactivation process, are heat stable and dialyzable (Xutong 
Wang, unpubl, obs.). It is unlikely that they are non-specific 
inhibitors of calcineurin such as inorganic phosphate or en- 
dogenous ubstrates because the crude enzyme or fraction A 
mixed with fraction B incubated in the presence of EGTA and 
assayed in the presence of Ca :÷ retains full activity. 
The relationship of the inactivating factor(s) reported in this 
study to FK506 and cyclosporin A remains to be ascertained. 
The endogenous factor(s) has no effect on purified 
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in the presence or absence of added FKBR This lack of effect 
contrasts to the pronounced inhibition of the purified enzyme 
by FK506 and cyclosporin A in the presence of their respective 
immunophilins. Inactivation of fraction A by fraction B does 
not require FKBP but the presence of cyclophilin in fraction 
A has not been ruled out. It is possible that inactivation by the 
endogenous ligand, like the one observed with the immunosup- 
pressive drugs, requires the presence of a specific binding pro- 
tein. Alternatively, the inactivating factor may regulate a yet 
unidentified enzyme activating or stabilizing calcineurin. Purifi- 
cation and characterization f the inactivating factor(s) is pres- 
ently under way in the laboratory. 
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